We are live on ! Find out more

IMCC

IM Cannabis

IMCC

Market cap $1.11M

1.83 USD

-0.11

5.67%

At close Updated Oct 7, 12:59 PM EDT

1 day

-5.67%

5 days

-24.38%

1 month

-6.63%

3 months

-60.65%

6 months

-82.42%

Year to date

-95.91%

1 year

-96.98%

5 years

-99.97%

10 years

-99.99%

About: IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority revenue is generated from Germany, and also has its presence in Israel.

Employees: 44

Healthcare Drug Manufacturers - Specialty & Generic

News

Positive

Neutral

Negative

Sentiment 3-Months

Positive 7.7%

Neutral 92.3%

Negative 0%

IM Cannabis Announces Closing of the Sale of IMC Holdings and Its European-Focused Operations, Strengthens Balance Sheet

Transaction Expected to Result in an Improvement of Approximately C$3 Million in Shareholders' Equity VANCOUVER, BC and GLIL YAM, Israel, Sept. 29, 2026 /PRNewswire/ -- IM Cannabis Corp. (the "Company") (NASDAQ: IMCC), today announced that, further to its press releases dated June 18, 2026 and August 17, 2026, it has completed the previously announced transaction contemplated by the definitive share purchase agreement dated August 16, 2026 (the "Share Purchase Agreement") among the Company, Slil.com Holding Ltd.

IM Cannabis Announces Closing of the Sale of IMC Holdings and Its European-Focused Operations, Strengthens Balance Sheet

IM Cannabis Announces Closing of US$1.31 Million Registered Direct Offering of Common Shares

VANCOUVER, BC and GLIL YAM, Israel, Sept. 24, 2026 /PRNewswire/ -- IM Cannabis Corp. ("IMCC" or the "Company") (Nasdaq: IMCC), a medical cannabis company with operations in Israel and Germany, today announced the closing of its previously announced registered direct offering (the "Offering"), pursuant to which the Company sold and issued 655,000 common shares, no par value per share (the "Common Shares"), to certain accredited investors at a purchase price of US$2.00 per Common Share, resulting in aggregate gross proceeds to the Company of US$1.31 million, before deducting offering expenses.

IM Cannabis Announces Closing of US$1.31 Million Registered Direct Offering of Common Shares

IM Cannabis Regains Compliance with Nasdaq Minimum Bid Price Requirement

VANCOUVER and GLIL YAM, Israel, Sept. 23, 2026 /PRNewswire/ -- IM Cannabis Corp. ("IMC" or the "Company") (Nasdaq: IMCC), a medical cannabis company with operations in Israel and Germany, today announced that on September 23, 2026, it received written notice from Nasdaq Stock Market LLC ("Nasdaq"), indicating that the Company has regained compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2), which requires listed securities to maintain a minimum bid price of $1.00 per share.

IM Cannabis Regains Compliance with Nasdaq Minimum Bid Price Requirement

IM Cannabis Announces Pricing of US$1.31 Million Registered Direct Offering of Common Shares

VANCOUVER, BC and GLIL YAM, Israel, Sept. 23, 2026 /PRNewswire/ -- IM Cannabis Corp. ("IMCC" or the "Company") (Nasdaq: IMCC), a medical cannabis company with operations in Israel and Germany, today announced that it has entered into securities purchase agreements with certain accredited investors for the purchase and sale of 655,000 common shares, no par value per share, at a purchase price of US$2.00 per share, pursuant to a registered direct offering, resulting in gross proceeds of approximately US$1.31 million at closing before offering expenses.

IM Cannabis Announces Pricing of US$1.31 Million Registered Direct Offering of Common Shares

IM Cannabis Enters Non-Binding Agreement to Acquire 51% of Space Defense Innovations, Operating in the European Tactical UAS Market

The Company has entered a non-binding Letter of Intent to acquire control of Space Defense Innovations LLC, which is engaged in distributing BlueBird Aero Systems' advanced tactical UAS and unique Hybrid Fixed-Wing VTOL-UAS platforms in Europe TORONTO and GLIL YAM, Israel, Sept. 23, 2026 /PRNewswire/ -- IM Cannabis Corp. ("IMCC" or the "Company") (Nasdaq: IMCC), today announced that it has entered into a non-binding Letter of Intent (the "LOI") to acquire 51% of the issued and outstanding equity securities of Space Defense Innovations LLC, a Polish limited liability company ("SDI"), on a fully diluted basis.

IM Cannabis Enters Non-Binding Agreement to Acquire 51% of Space Defense Innovations, Operating in the European Tactical UAS Market

IM Cannabis Raises US$225,000 of Gross Proceeds in Convertible Note Financing

TORONTO and GLIL YAM, Israel, Sept. 2, 2026 /PRNewswire/ -- IM Cannabis Corp. ("IMCC" or the "Company") (Nasdaq: IMCC), a medical cannabis company with operations in Israel and Germany, today announced the closing of a US$225,000 convertible note financing in a private placement with an institutional investor (the "Lender").

IM Cannabis Raises US$225,000 of Gross Proceeds in Convertible Note Financing

IM Cannabis Shares Commence Trading on 30:1 Consolidated Basis

TORONTO and GLIL YAM, Israel, Aug. 27, 2026 /PRNewswire/ -- IM Cannabis Corp. ("IMC" or the "Company") (Nasdaq: IMCC), a medical cannabis company with operations in Israel and Germany, announces that, further to its press release dated August 18, 2026, the Company's common shares, no par value per share ("Common Shares"), commenced trading today on the Nasdaq Capital Market LLC ("Nasdaq") on a 30:1 post-consolidated basis (the "Consolidation"). The Company's existing trading symbol "IMCC" remains unchanged.

IM Cannabis Shares Commence Trading on 30:1 Consolidated Basis

IM Cannabis Announces Intention to Complete 30:1 Share Consolidation to Support Nasdaq Minimum Bid Price Compliance

TORONTO and GLIL YAM, Israel, Aug. 18, 2026 /PRNewswire/ -- IM Cannabis Corp. ("IMC" or the "Company") (Nasdaq: IMCC), a medical cannabis company with operations in Israel and Germany, announces that the board of directors of the Company (the "Board") has approved a consolidation of its issued and outstanding common shares, no par value per share ("Common Shares") on the basis of one post-consolidated Common Share for every thirty pre-consolidated Common Shares (the "Consolidation"). The Board has authorized the Consolidation to be effected on or before September 15, 2026, with the Company currently expecting August 27, 2026 to be the effective date of the Consolidation (the "Effective Date").

IM Cannabis Announces Intention to Complete 30:1 Share Consolidation to Support Nasdaq Minimum Bid Price Compliance

IM Cannabis Leverages Restructuring Deal to Reduce Financial Strain

IM Cannabis Corp. (NASDAQ:IMCC) on Monday agreed to divest its subsidiary IMC Holdings Ltd. to Slil.com Holding Ltd.

IM Cannabis Leverages Restructuring Deal to Reduce Financial Strain

IM Cannabis Enters into Agreement to Sell IMC Holdings and European- Focused Assets

Transaction Expected to Result in an Improvement of Approximately CAD$3 million in Shareholders' Equity TORONTO and GLIL YAM, Israel, Aug. 17, 2026 /PRNewswire/ -- IM Cannabis Corp. ("IMC" or the "Company") (Nasdaq: IMCC), today announced that, further to its press release dated June 18, 2026, it has entered into a definitive share purchase agreement dated August 16, 2026 (the "Share Purchase Agreement") with Slil.com Holding Ltd. ("Slil") and I.M.C.

IM Cannabis Enters into Agreement to Sell IMC Holdings and European- Focused Assets

See News Rankings

Price charts implemented using Lightweight Charts™